secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0000950170-24-006051
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences shareholders approve reverse stock split (1:2 to 1:50)
-----------------------------------------------------------------------------

- Reverse stock split authorized with ratio range 1-for-2 to 1-for-50; board to set exact ratio within one year.
- Proposal 1 votes: 1,410,313 For, 831,173 Against, 2,562 Abstain.
- Proposal 2 to adjourn if needed also approved: 1,676,035 For, 551,758 Against, 16,255 Abstain.
- Special Meeting held Jan 17, 2024; quorum of 2,244,048 shares of 6,297,303 outstanding.
- Board has sole discretion to implement split at any time within one year without further shareholder vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024006051/0000950170-24-006051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024006051/revb-20240117.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-006051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer